Press Release

Cooley #1 in Biotech & Pharma Licensing

March 16, 2016

San Francisco – March 16, 2016 – BioPharm Insight League Tables ranked Cooley #1 in biotech & pharma licensing for both value and volume across the following categories:

  • 2015 Global BioPharm Insight Licensing League Table; 23 deals, $7.8 billion
  • 2015 North America Licensing League Table; 22 deals, $7.8 billion
  • Q4 2015 Licensing League Table; 13 deals, $3.4 billion

"These rankings demonstrate Cooley's continued prominence in the life sciences sector," said Barbara Kosacz, partner and head of the firm's life sciences practice. "We have a talented group of individuals whose collective knowledge and expertise in the field help achieve unparalleled success for our clients."

Earlier this month, for the third year in a row, Cooley was ranked the #1 most active law firm for life sciences venture financings according to data from VentureSource.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has 900 lawyers across 12 offices in the United States, China and Europe.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.